Kerry Wentworth, VP, Clinical, Reg & Qual at AGENUS INC (AGEN), sold 5,000 shares at $5.00 ($25K) on 2014-02-26, disclosed to the SEC on 2014-02-28.
Scheduled sale ($25k) by VP, Clinical, Reg & Qual under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NUVB | SELL | 2026-04-08 | $904K | — | Filing → |
| NUVB | BUY | 2025-06-18 | $90K | — | Filing → |
| FLXN | SELL | 2021-07-20 | $25K | — | Filing → |